Allergy immunotherapy with a hypoallergenic recombinant birch pollen allergen rBet v 1-FV in a randomized controlled trial

BACKGROUND: Pollen extracts and chemically modified allergoids are used successfully in allergen immunotherapy (AIT). Recombinant extracts offer potential advantages with respect to pharmaceutical quality, standardization and dosing. A hypoallergenic recombinant folding variant of the major birch po...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Clin Transl Allergy
Egile Nagusiak: Klimek, Ludger, Bachert, Claus, Lukat, Karl-Friedrich, Pfaar, Oliver, Meyer, Hanns, Narkus, Annemie
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2015
Gaiak:
Brief Communication
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4553934/
https://ncbi.nlm.nih.gov/pubmed/26328056
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13601-015-0071-x
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak